BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Panacea Biotec receives LoA from CMSS
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The campaign builds on the three-year partnership unveiled earlier this season
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
Subscribe To Our Newsletter & Stay Updated
